KRTL BioTech

Goldman Sachs is shrinking its SPAC business amid regulatory crackdown and market turmoil

Goldman Sachs is shrinking its SPAC business amid regulatory crackdown and market turmoil

Goldman is scaling back its business in SPACs as blank-check deals got caught in a double whammy of regulatory crackdown and tough market environment.